Careteq Half-Year Loss Widens as Revenue Declines and NTA Stays Negative

An announcement from Careteq Ltd. ( (AU:CTQ) ) is now available.

Careteq Limited reported a challenging first half for the period ended 31 December 2025, with revenue from ordinary activities from continuing operations down 18.0% to $51,003 and no dividends declared or paid. The company’s comprehensive loss after tax widened to $277,931, while the loss from ordinary activities after tax from continuing operations attributable to owners increased 22.8% to $922,188, and net tangible assets per share remained negative, highlighting ongoing financial pressure and a continued need for capital discipline.

The half-year figures indicate a deterioration in profitability compared with the prior corresponding period, when the comprehensive loss stood at $150,152, underscoring the strain on Careteq’s balance sheet as it navigates its market. With no changes in control of subsidiaries, no associates or joint ventures, and no dividend reinvestment plan in place, the results point to a business still in an investment or turnaround phase, which may weigh on shareholder returns in the near term while the company works to stabilise revenue and improve its financial position.

The most recent analyst rating on (AU:CTQ) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on Careteq Ltd. stock, see the AU:CTQ Stock Forecast page.

More about Careteq Ltd.

Careteq Limited is an Australian-listed company that provides technology-enabled care solutions, with a focus on monitoring and support services for vulnerable or at-risk individuals. The company operates in the healthcare and aged care technology sector, aiming to deliver connected care platforms that improve safety, independence and efficiency for patients, carers and service providers.

Average Trading Volume: 578,509

Technical Sentiment Signal: Sell

See more data about CTQ stock on TipRanks’ Stock Analysis page.